Evoke Pharma Inc Quarterly Operating Lease, Payments in USD from Q3 2021 to Q4 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Evoke Pharma Inc quarterly/annual Operating Lease, Payments history and growth rate from Q3 2021 to Q4 2023.
- Evoke Pharma Inc Operating Lease, Payments for the quarter ending December 31, 2023 was $25.7K.
- Evoke Pharma Inc Operating Lease, Payments for the twelve months ending December 31, 2023 was $146K, a 274% increase year-over-year.
- Evoke Pharma Inc annual Operating Lease, Payments for 2023 was $146K, a 274% increase from 2022.
- Evoke Pharma Inc annual Operating Lease, Payments for 2022 was $39K, a 71.5% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)